Segment & Geographic Data
Quant-Grade Normalized (live API)
API & CSV Delivery
Cronos Group Inc's Business Segments
Cronos Group Inc's reported revenue by business segment and by geographic region, quarterly and annual, normalized against the consolidated income statement. Free below: the top 3 rows per table, this quarter and this fiscal year. Subscriber access adds the full segment history and operating income by segment.
Segment Data As of FY
Reportable Segments
5
Largest Segment
Cannabis flower
Total Revenue
$ 124
Regions Reported
1
Revenue Share by Reportable Segment - FY
- Cannabis flower59%
- Canada43.7%
- Israel23.6%
- Other countries12.1%
- Other0%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Cannabis flower | $ 73 | 59% |
| Canada | $ 54 | 43.7% |
| Israel | $ 29 | 23.6% |
2 more segments available
Sign in to unlock the full Cronos Group Inc dataset.
Revenue Share by Region - FY
- Other countries12.6%
Revenue by Geographic Region - FY
| Region | Revenue (Millions) | % of Total |
|---|---|---|
| Other countries | $ 6 | 12.6% |
Revenue by Product & Service Category - FY
- Cannabis flower74.6%
- Cannabis extracts25.3%
- Product and Service, Other0%
Revenue by Product & Service Category - FY
| Category | Revenue (Millions) | % of Total |
|---|---|---|
| Cannabis flower | $ 34 | 74.6% |
| Cannabis extracts | $ 11 | 25.3% |
| Product and Service, Other | $ 0 | 0% |
Product and service categories are a supplemental disclosure and are not required to sum to consolidated revenue or to the reportable segments above.
Annual Results
Revenue Share by Reportable Segment - FY
- Cannabis flower59%
- Canada43.7%
- Israel23.6%
- Other countries12.1%
- Other0%
Revenue by Reportable Segment - FY
| Segment | Revenue (Millions) | % of Total |
|---|---|---|
| Cannabis flower | $ 73 | 59% |
| Canada | $ 54 | 43.7% |
| Israel | $ 29 | 23.6% |
2 more segments available
Sign in to unlock the full Cronos Group Inc dataset.
Description of Cronos Group Inc
Cronos Group Inc is a Canadian cannabis company that operates globally. It was founded in 2013 by two entrepreneurs, and it was one of the first companies to receive a cultivation license from Health Canada. The company is publicly traded on the Toronto Stock Exchange and the NASDAQ.
Cronos Group has established itself as a leading player in the cannabis industry. It operates through its three wholly-owned subsidiaries: Cronos Growing Company Inc, Cronos Israel, and Cronos Australia. These subsidiaries focus on the cultivation, production, and distribution of cannabis products.
One of the key strengths of Cronos Group is its diverse portfolio of brands and products. The company's offerings include dried flower, oils, pre-rolls, vapes, and cannabis-infused beverages. It has also gained a reputation for developing innovative and high-quality products by leveraging advanced research and development capabilities.
Cronos Group has a strong international presence. It has strategically entered into partnerships and agreements with companies in various countries to expand its global footprint. For example, it has an exclusive distribution agreement with Delfarma, a leading pharmaceutical distributor in Poland. Additionally, Cronos Group has partnered with Kibbutz Gan Shmuel, an agricultural community in Israel, to establish a state-of-the-art cultivation facility.
The company's commitment to research and development sets it apart in the industry. Cronos Group invests significantly in scientific research to develop new cannabis products and to improve the efficiency of cultivation and extraction processes. It has established a cutting-edge research and development facility to drive innovation and create a competitive advantage.
Cronos Group prioritizes sustainable and responsible operations. It is focused on minimizing its environmental impact and ensuring the health and safety of its employees. The company has implemented various initiatives to promote sustainability, such as adopting energy-efficient technologies and reducing water consumption in its cultivation facilities.
In addition to its core cannabis business, Cronos Group is actively exploring opportunities in the hemp-derived CBD market. It has launched various CBD products, including topicals and tinctures, to capitalize on the growing demand for CBD-infused products.
Despite its strong position in the industry, Cronos Group faces challenges and risks. The cannabis market is highly regulated, and changes in regulations could impact the company's operations. Additionally, increased competition, both domestically and internationally, poses a threat to its market share and profitability.
In conclusion, Cronos Group Inc is a leading Canadian cannabis company with a global presence. It has established itself as an innovative and sustainable player in the industry, with a diverse portfolio of cannabis products. The company's ongoing investments in research and development, along with strategic partnerships, position it for growth in the evolving cannabis market.
Cronos Group has established itself as a leading player in the cannabis industry. It operates through its three wholly-owned subsidiaries: Cronos Growing Company Inc, Cronos Israel, and Cronos Australia. These subsidiaries focus on the cultivation, production, and distribution of cannabis products.
One of the key strengths of Cronos Group is its diverse portfolio of brands and products. The company's offerings include dried flower, oils, pre-rolls, vapes, and cannabis-infused beverages. It has also gained a reputation for developing innovative and high-quality products by leveraging advanced research and development capabilities.
Cronos Group has a strong international presence. It has strategically entered into partnerships and agreements with companies in various countries to expand its global footprint. For example, it has an exclusive distribution agreement with Delfarma, a leading pharmaceutical distributor in Poland. Additionally, Cronos Group has partnered with Kibbutz Gan Shmuel, an agricultural community in Israel, to establish a state-of-the-art cultivation facility.
The company's commitment to research and development sets it apart in the industry. Cronos Group invests significantly in scientific research to develop new cannabis products and to improve the efficiency of cultivation and extraction processes. It has established a cutting-edge research and development facility to drive innovation and create a competitive advantage.
Cronos Group prioritizes sustainable and responsible operations. It is focused on minimizing its environmental impact and ensuring the health and safety of its employees. The company has implemented various initiatives to promote sustainability, such as adopting energy-efficient technologies and reducing water consumption in its cultivation facilities.
In addition to its core cannabis business, Cronos Group is actively exploring opportunities in the hemp-derived CBD market. It has launched various CBD products, including topicals and tinctures, to capitalize on the growing demand for CBD-infused products.
Despite its strong position in the industry, Cronos Group faces challenges and risks. The cannabis market is highly regulated, and changes in regulations could impact the company's operations. Additionally, increased competition, both domestically and internationally, poses a threat to its market share and profitability.
In conclusion, Cronos Group Inc is a leading Canadian cannabis company with a global presence. It has established itself as an innovative and sustainable player in the industry, with a diverse portfolio of cannabis products. The company's ongoing investments in research and development, along with strategic partnerships, position it for growth in the evolving cannabis market.
Cronos Group Inc. reports through a single consolidated segment encompassing operations in Canada and Israel. In Canada, the company operates Peace Naturals Project Inc., a wholly owned license holder with production facilities in Stayner, Ontario, and consolidates Cronos GrowCo, in which it holds a 50% equity interest. Both Canadian entities are licensed under the Cannabis Act for the cultivation, processing, distribution, and sale of cannabis products. In Israel, Cronos operates under IMC-GAP, IMC-GMP, and IMC-GDP certifications for medical cannabis cultivation, production, distribution, and marketing. Outside of Canada and Israel, Cronos distributes PEACE NATURALS® and LIT™ branded and white-labeled cannabis products to select international markets and plans further expansion. The company pursues strategic international opportunities subject to regulatory approvals and operates only in jurisdictions where its business activities comply with legal requirements and TSX and Nasdaq listing obligations.